AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-26126814_ITM" title="Facts and information about ONCOTHERAPY SCIENCE DEVELOPS LARGE-INTESTINE CANCER VACCINE.">ONCOTHERAPY SCIENCE DEVELOPS LARGE-INTESTINE CANCER VACCINE.</a>
Close
Set up an RSS feed that alerts you when new articles from AsiaPulse News are available.
Frequently asked questions about RSS feeds
ONCOTHERAPY SCIENCE DEVELOPS LARGE-INTESTINE CANCER VACCINE.
TOKYO, Oct 1 Asia Pulse - Oncotherapy Science Inc., a biotech start-up, has recently developed a vaccine against cancer of the large intestine by using human genome data.
The venture has confirmed that the vaccine can boost the body's immune system and help destroy cancer cells at a high rate.
Oncotherapy Science will launch clinical tests as early as next fiscal year, with the goal of commercializing the vaccine by around 2010. The firm has the exclusive right to commercialize the research results of Yusuke Nakamura, a professor at the Institute of Medical ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- BIOWA, ONCOTHERAPY SCIENCE COLLABORATE ON ANTICANCER ANTIBODIES.
- News wire article from: AsiaPulse News October 24, 2005 700+ words
...AsiaNet/ - BioWa, Inc. and OncoTherapy Science, Inc. today announced that the...monoclonal antibodies (Mabs). OncoTherapy Science will employ its technology for identification...Under this collaboration, BioWa and OncoTherapy Science will carry out research and development...
- BioWa and OncoTherapy Science Announce Collaboration to Develop Anticancer...
- Press release article from: PR Newswire Europe October 24, 2005 700+ words
...PRNewswire/ -- BioWa, Inc. and OncoTherapy Science, Inc. today announced that the...monoclonal antibodies (Mabs). OncoTherapy Science will employ its technology for identification...Under this collaboration, BioWa and OncoTherapy Science will carry out research and development...
- ONCOTHERAPY SCIENCE, BIOWA TEAM ON CANCER ANTIBODY DRUGS.
- News wire article from: AsiaPulse News August 10, 2004 700+ words
...Asia Pulse - Cancer drug developer OncoTherapy Science Inc. (TSE:4564) announced Monday...Hakko Kogyo Co. (TSE:4151) . OncoTherapy Science leverages the results of gene analysis...technology on antibodies created by OncoTherapy Science, the two companies aim to create...
- ONCOTHERAPY SCIENCE READYING CLINICAL TRIALS ON CANCER VACCINES.
- News wire article from: AsiaPulse News January 10, 2008 700+ words
...TOKYO, Jan 10 Asia Pulse - OncoTherapy Science Inc. (TSE:4564) expects...they have come down with. OncoTherapy Science has synthesized protein...cancer proliferation. OncoTherapy Science has been developing this...
- EISAI, ONCOTHERAPY SCIENCE TEAM UP IN LUNG CANCER GENE TESTS.
- News wire article from: AsiaPulse News November 14, 2003 700+ words
...announced a partnership with bioventure OncoTherapy Science Inc. to develop gene tests for...the cancer-related proteins . OncoTherapy Science has technology for analyzing the...diagnostics with a leading drug company. OncoTherapy Science will provide information on genes...
- JAPAN'S BANYU, ONCOTHERAPY SCIENCE ALLY ON LIVER CANCER DRUG.
- News wire article from: AsiaPulse News July 23, 2002 700+ words
TOKYO, July 23 Asia Pulse - Banyu Pharmaceutical Co. (TSE:4515) has tied up with biotechnology venture Oncotherapy Science KK on the development of a genome-based treatment for liver cancer. They aim to identify candidate compounds for...
- Patent No. 07601826 Issued on Oct. 13, Assigned to Oncotherapy Science, Inc....
- News wire article from: US Fed News Service, Including US State News October 15, 2009 700+ words
...pancreatic cancers .The inventors were issued U.S. Patent No. 07601826 on Oct. 13. The patent has been assigned Oncotherapy Science, Inc., Kanagawa. According to the abstract released by the U.S. Patent & Trademark Office: The present...
- Patent No.7,569,351 Issued on Aug. 4, Assigned to Oncotherapy Science for Novel...
- News wire article from: US Fed News Service, Including US State News August 7, 2009 700+ words
...protein. The inventors were issued U.S. Patent No. 7,569,351 on Aug. 4. The patent has been assigned to Oncotherapy Science Inc., Kanagawa. According to the abstract released by the U.S. Patent & Trademark Office: "A novel...